Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bio-Rad Laboratories

234.41
+0.0000
Volume:5.00
Turnover:1.24K
Market Cap:6.57B
PE:-3.59
High:234.41
Open:234.41
Low:234.41
Close:234.41
Loading ...

Bio-Rad Laboratories Q4 2024 Adj EPS $2.90 Beats $2.86 Estimate, Sales $667.50M Miss $679.30M Estimate

Benzinga
·
14 Feb

Bio-Rad Offers to Acquire Digital PCR Developer Stilla Technologies

Business Wire
·
14 Feb

Oncocyte Prices $29 Million Stock Offerings

MT Newswires Live
·
11 Feb

Wells Fargo Sticks to Their Hold Rating for Bio-Rad Laboratories (BIO)

TIPRANKS
·
10 Feb

Earnings Preview: Bio-Rad Laboratories (BIO) Q4 Earnings Expected to Decline

Zacks
·
06 Feb

Has BioRad Laboratories (BIO) Outpaced Other Medical Stocks This Year?

Zacks
·
04 Feb

RBC Trims Price Target on Bio-Rad Laboratories to $477 From $481, Keeps Outperform Rating

MT Newswires Live
·
04 Feb

Bio-Rad Laboratories, Inc. (BIO): Is This Healthcare Stock A Good Buy?

Insider Monkey
·
29 Jan

Press Release: Bio-Rad to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, February 13, 2025

Dow Jones
·
28 Jan

Strong week for Bio-Rad Laboratories (NYSE:BIO) shareholders doesn't alleviate pain of three-year loss

Simply Wall St.
·
28 Jan

Is Adaptive Biotechnologies (ADPT) Stock Outpacing Its Medical Peers This Year?

Zacks
·
17 Jan

Bio-Rad Laboratories Price Target Maintained With a $481.00/Share by RBC Capital

Dow Jones
·
15 Jan

Bio-Rad Laboratories Led $105 Million Series C Funding Round for Geneoscopy

MT Newswires Live
·
08 Jan

Geneoscopy Closes $105M in Series C Funding Round to Power Next-Generation of Gastrointestinal Diagnostic Tests

Business Wire
·
08 Jan

Getting In Cheap On Bio-Rad Laboratories, Inc. (NYSE:BIO) Is Unlikely

Simply Wall St.
·
07 Jan

Bio-Rad’s Management to Host Investor Meetings at J.P. Morgan's 43rd Annual Healthcare Conference

Business Wire
·
03 Jan

At US$331, Is It Time To Put Bio-Rad Laboratories, Inc. (NYSE:BIO) On Your Watch List?

Simply Wall St.
·
26 Dec 2024

Is Bio-Rad Laboratories (NYSE:BIO) Using Too Much Debt?

Simply Wall St.
·
17 Dec 2024

Bio-Rad Laboratories Is Maintained at Outperform by RBC Capital

Dow Jones
·
09 Dec 2024

RBC Raises Price Target on Bio-Rad Laboratories to $481 From $469, Keeps Outperform Rating

MT Newswires Live
·
09 Dec 2024